Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028353 · ClinicalTrials.gov registry record · Phase 2
A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
A Phase 2 study, sponsored by GTx.
- Completed
- Registry status
- Phase 2
- Development phase
- 500
- Enrollment target
NCT00028353 is a Phase 2 study that has completed, run by GTx. The registered enrollment target is 500 participants.
The verdict
NCT00028353, a Phase 2 study, has completed, sponsored by GTx.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 500 participants
- Enrollment target
Study Summary
If you are a male 30 years of age or older and have a positive diagnosis of high grade (II or III) prostate Intraepithelial Neoplasia (PIN) or have had an abnormal/suspicious prostate biopsy, you may be eligible for this study. This is a study of an investigational medication that may reduce high grade PIN and prevent the occurrence of prostate cancer. This study is currently enrolling up to 500 men at approximately 60 locations in the United States.
Interventions
- DRUG GTX-006 (Acapodene)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2001-04 |
| Est. Completion | 2003-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00028353
The ClinicalTrials.gov registry entry for NCT00028353 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GTx, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GTX-006 (Acapodene) is the first listed.
NCT00028353 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00028353 about?
NCT00028353 is a clinical study titled "A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)". If you are a male 30 years of age or older and have a positive diagnosis of high grade (II or III) prostate Intraepithelial Neoplasia (PIN) or have had an abnormal/suspicious prostate biopsy, you may be eligible for this study. This is a study of an investigational medication that may reduce high gr...
What is the current status of trial NCT00028353?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 500 participants. The study started on 2001-04. Estimated completion is 2003-07.
What interventions are being tested in trial NCT00028353?
The interventions under investigation include: GTX-006 (Acapodene) (DRUG).
Who is sponsoring clinical trial NCT00028353?
This trial is sponsored by GTx, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.